News
3h
TipRanks on MSNElicio Therapeutics Publishes Promising Phase 1 Study DataElicio Therapeutics ( (ELTX) ) just unveiled an announcement. On August 12, 2025, Elicio Therapeutics announced the publication of follow-up data from its Phase 1 AMPLIFY-201 study in Nature Medicine ...
The Telangana Council of Higher Education (TGCHE) has announced the Telangana State Education Common Entrance Test (TS/TG ...
The Adani Group will reportedly invest nearly Rs 30,000 crore in the third phase of the Navi Mumbai International Airport ...
3h
TipRanks on MSNElicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 dataElicio Therapeutics (ELTX) announced the publication of follow-up data from the Phase 1 AMPLIFY-201 study evaluating ELI-002 in the peer-reviewed ...
1d
GMA Network on MSNPhase 1 of EDSA Busway rehab begins Monday, Aug. 11, 2025Phase 1 of the EDSA Busway rehabilitation began on Monday, August 11, 2025, focusing on improvements to four of its stations.
Eli Lilly and Company (NYSE: LLY) is one of the Good Stocks to Invest in Now. On August 7, Eli Lilly and Company (NYSE:LLY) ...
Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the ...
5d
WTEN Albany on MSNAlbany International Airport completes phase 1 of concourse upgradesThe Albany International Airport has completed the first phase of its Concourse A Rehabilitation Project. Phase one included ...
Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to ...
Pegozafermin, ETNB's FGF21 analog, shows promise in late-stage trials for MASH & severe hypertriglyceridemia. Key data & ...
Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results